Download PDF
Nuklearmedizin 2013; 52(06): N66-N67
DOI: 10.1055/s-0038-1625227
Case report
Schattauer GmbH

18F-FDG PET/CT uptake due to poly-L-lactic acid facial injections

18 F-FDG-PET/CT-Aufnahme aufgrund von Poly-L-Milchsäure-Gesichtsinjektionen
D. Métivier
1   Department of Nuclear Medicine, University Hospital Tenon, AP-HP & Université Pierre et Marie Curie (UPMC), Paris, France
,
F. Montravers
1   Department of Nuclear Medicine, University Hospital Tenon, AP-HP & Université Pierre et Marie Curie (UPMC), Paris, France
,
S. Balogova
1   Department of Nuclear Medicine, University Hospital Tenon, AP-HP & Université Pierre et Marie Curie (UPMC), Paris, France
2   Comenius University, Bratislava, Slovakia
,
J.-N. Talbot
1   Department of Nuclear Medicine, University Hospital Tenon, AP-HP & Université Pierre et Marie Curie (UPMC), Paris, France
› Author Affiliations
Further Information

Publication History

received: 25 March 2013

accepted in revised form: 26 August 2013

Publication Date:
11 January 2018 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Barton SE, Engelhard P, Conant M. Poly-L-lactic acid for treating HIV-associated facial lipoatrophy: a review of the clinical studies. Int J STD AIDS 2006; 17: 429-435.
    CrossrefGoogle Scholar
  • 2 Bassichis B, Blick G, Conant M. et al. Injectable poly-l-lactic acid for human immunodeficiency virus-associated facial lipoatrophy: cumulative year 2 interim analysis of an open-label study (FACES). Dermatol Surg 2012; 38: 1193-1205.
    CrossrefGoogle Scholar
  • 3 James J, Carruthers A, Carruthers J. HIV-associated facial lipoatrophy. Dermatol Surg 2002; 28: 979-986.
    Google Scholar
  • 4 Kates LC, Fitzgerald R. Poly-L-lactic acid injection for HIV-associated facial lipoatrophy: treatment principles, case studies, and literature review. Aesthet Surg J 2008; 28: 397-403.
    CrossrefGoogle Scholar
  • 5 Levy RM, Redbord KP, Hanke CW. Treatment of HIV lipoatrophy and lipoatrophy of aging with poly-L-lactic acid: a prospective 3-year follow-up study. J Am Acad Dermatol 2008; 59: 923-933.
    CrossrefGoogle Scholar